• LAST PRICE
    37.3000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    15.0000/ 1
  • Ask / Lots
    59.3000/ 1
  • Open / Previous Close
    0.0000 / 37.3000
  • Day Range
    ---
  • 52 Week Range
    Low 26.0600
    High 50.1800
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 36.75
TimeVolumeSMTI
11:06 ET10035.95
11:22 ET23736.035
12:25 ET130035.83
12:38 ET40036.02
12:39 ET27536.23
01:21 ET11236.15
01:55 ET10036.69
02:08 ET10036.52
02:29 ET10036.95
02:45 ET80036.9
02:49 ET64036.7501
02:51 ET20036.6
02:54 ET43736.52
03:54 ET10037.015
03:56 ET10036.55
03:57 ET100037.348
03:59 ET20037.3
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSMTI
Sanara Medtech Inc
321.6M
-37.3x
---
United StatesAQST
Aquestive Therapeutics Inc
349.3M
-28.5x
---
United StatesTBPH
Theravance Biopharma Inc
434.0M
-9.3x
---
United StatesRDY
Dr Reddy's Laboratories Ltd
12.1B
19.2x
+32.29%
United StatesMRNS
Marinus Pharmaceuticals Inc
483.6M
-3.4x
---
United StatesPGEN
Precigen Inc
360.9M
-3.7x
---
As of 2024-03-28

Company Information

Sanara MedTech Inc. is a medical technology company. The Company is focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. It has products across surgical and chronic wound care applications and has multiple products in its pipeline. Its surgical products include CellerateRX Surgical Activated Collagen, TEXAGEN, BiFORM, AMPLIFY and ALLOCYTE, FORTIFY TRG Tissue Repair Graft, and FORTIFY FLOWABLE Extracellular Matrix are used in a range of surgical specialties to help promote patient healing and reduce the risk of complications. Its chronic wound care products include HYCOL Hydrolyzed Collagen, BIAKOS Antimicrobial Skin and Wound Cleanser and BIAKOS Antimicrobial Wound Gel, are targeted for use across the post-acute continuum of care, including home health, hospice, physician offices, podiatrists, retail, skilled nursing facilities and wound care clinics.

Contact Information

Headquarters
1200 Summit Avenue, Suite 414FORT WORTH, TX, United States 76102
Phone
817-529-2300
Fax
---

Executives

Director
Ronald Nixon
Chief Executive Officer
Zachary Fleming
Chief Financial Officer
Michael McNeil
Director
Ann Salamone
Independent Director
Robert DeSutter

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$321.6M
Revenue (TTM)
$62.6M
Shares Outstanding
8.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.57
EPS
$-1.00
Book Value
$5.04
P/E Ratio
-37.3x
Price/Sales (TTM)
5.1
Price/Cash Flow (TTM)
---
Operating Margin
-12.84%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.